Date of Award
Chemistry and Biochemistry
Type 2 diabetes is a complex disease that affects a large population of people. It is imperative that efforts are made to develop more effective and inclusive treatment strategies for patients with this condition. A promising approach being studied is the utilization of community pharmacists to individualize and implement diabetes self-management training and education. The objective of this study is to develop a preliminary version of a patient decision aid (PDA) designed to evaluate patient knowledge and behavior towards diabetes self-management for use in the community pharmacy setting. The study design used to achieve this objective was a cross-sectional survey applying a modified Delphi-procedure. The survey consisted of 59 questions and asked participants to rank the difficulty of each question, to determine whether the item should be included or removed, and to include any additional comments or recommendations for further development of the PDA. It was completed by faculty members at the University of Mississippi School of Pharmacy and practicing community pharmacists throughout the region. Most respondents felt that the proposed questions should be retained, especially after the implementation of the recommended edits given by respondents. It was found that the difficulty rankings were relatively balanced between “Low”, “Medium”, and “High” difficulty; however, it is noted that more “High” difficulty questions should be created in the future in order to assess a broader scope of the patient’s knowledge. Additionally, it was concluded the PDA could become more patient-friendly through the re-wording of questions in future versions of the PDA. Overall, the assessment of the developed PDA provides the momentum necessary for the further improvement of patients’ self-management of diabetes.
Baker, Morgan, "Improving Diabetes Self-Management Developing a Patient Decision Aid to Improve Patient Education" (2020). Honors Theses. 1352.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.